<DOC>
	<DOCNO>NCT01813682</DOCNO>
	<brief_summary>The purpose study determine whether iron-fortified TPN effective preventative treatment preterm infant . Preterm infant risk anemia especially preterm infant . Generally small Birth weight gestational age high anemia rate infant . About 25 % 85 % preterm infant develop evidence anemia infancy，77 % VLBW（very low birth weight） infant develop anemia hospital stay . The effect iron deficiency pervasive involve multiple organ system . Poor physical growth , gastrointestinal disturbance , thyroid dysfunction , alter immunity temperature instability attribute iron deficiency low birth weight infant . So important provide iron preterm infant . As enteral nutrition feasible soon birth preterm infant , Parenteral iron administration efficacious method u select . For preterm infant use TPN ( total parenteral nutrition ) common first ten day life , hypothesis iron-fortified TPN may preventative treatment effect preterm infant use TPN supplementation oral nutrition ; Iron-fortified TPN ( total parenteral nutrition ) also improve iron store status preterm infant . The high concentration iron use study large preventative treatment effect preterm infant anemia ; It safe add Small dose iron agent TPN .</brief_summary>
	<brief_title>Effect Iron-fortified TPN Preterm Infants Anemia</brief_title>
	<detailed_description>Preterm infant high risk anemia especially low birth weight infant , important supply iron infant group . 90 preterm infant BW ( birth weight ) less 2kg , enter neonatal intensive care unit ( NICU ) less 72 hour meet Inclusion Criteria study Randomly divide three group , control group、 treatment group1 ( 200μg/kg/d , high concentration iron ≤0.8g/100ml TPN ) 、treatment group2 （400μg/kg/d , high concentration iron ≤0.8g/100ml TPN） . iron supplementation period ten day . For three group , complete blood count , differential count , reticulocyte count measure weekly sample obtain , serum iron , iron protein , total iron bind force measure baseline 2 week . Through comparative analysis three group , find iron-fortified TPN whether affect anemia rate iron storage preterm . also select malondialdehyde ( MDA ) 8-iso-prostaglandin F2α ( 8-iso-PGF2α ) concern iron use TPN induces oxidative stress index . Iron protein determination use radioimmunoassay method , serum iron total iron bind force determination use chemical method , MDA 8-iso-PGF2α determination use enzyme-linked immunosorbent assay method .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Preterm infant birth weight less 2kg Have parenteral nutrition indication With write informed consent parent guardian already use TPN randomization Kidney liver function abnormal hemolytic disease hemorrhagic disease Serious congenital malformation septicemia plethora newborn use TPN less ten day</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Days</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>preterm infant</keyword>
	<keyword>anemia</keyword>
	<keyword>iron fortify TPN</keyword>
</DOC>